抗体效价(log2)
: K' \, s7 C9 j9 Q* I* d8 q9 ~ | 攻毒数 3 T, b4 ]1 y/ D3 w+ d1 u
| 死亡数
( ]$ l2 v+ M( T* A$ E* M5 [: y" H | 存活数
% U6 e/ w( e7 I7 P: H; E: z8 b7 V: x | 保护率% : H, m4 V0 w; C! v
|
07 ]8 L3 U* z8 D) t
| 6
2 X/ K% ^4 @1 a1 x m! y# n | 6) U v. h9 L7 V! ?$ r# c3 E) w
| 09 a# ^, b/ }, M8 w" m* t% V
| 0/ X' @# ?/ x2 F6 p
|
1
0 U9 a. B: q$ ] T& z | 6
[! Q. }( T$ x. d c! v' P | 6+ G( u( R/ [! |) h
| 0
1 L/ [$ t- T) M7 B8 C( u1 s | 0$ d& W6 X- S/ e6 a9 z! b# v+ A
|
2 . x( _( D/ p6 a4 a% ]7 q
| 6
$ ] F7 e3 i+ w# H9 O0 v | 3 / w6 x. k s# f- s
| 3 , O( u. |6 D" b
| 50
6 m2 _" r/ H, V% ?2 h* c* h* L |
3
- A2 I% u& K- {$ c. X | 6 . Z( G0 Q1 e4 s% A- f) j
| 0
+ e7 q, l5 ~" ? | 6
4 ?, j o; ^' t4 z/ j, H% D9 R: ] | 100 # E* N& a# {+ I; b+ ]' N6 X
|
4 + `" o" T# y! ]( h
| 6 $ t4 J& J1 t* D7 @4 G4 C6 l9 v
| 0 + i4 m3 ~ f' f' q
| 6 # |) D8 F; S7 S5 a5 \" c+ c- S4 C
| 100 * K, S' C7 L% s6 F
|
2 g9 ^3 G0 |( Z1 J日龄
9 a% }! u# K8 C( o( I$ b |
) K; O- r. y/ P5 b7 P免疫后
4 G. d) `, g, a6 K' d |
1周 ; J0 k6 K6 r& U1 D6 D2 u
| 2周
' n/ e; A) R, u2 C8 u | 3周 9 L7 L) ] s5 ^3 ^4 ?. S; f
| 4周 ; |1 d1 F5 p: h0 ?& b$ z6 t
| 5周
7 d3 D2 n" O, E/ ]( i [( O | 6周 & E2 l1 A* v# A. [
| 7周 % z3 i2 ~7 C1 S D* |
| 8周
8 N5 P" E' H$ ^2 T |
30$ i- C- r$ Q. m9 _3 K: `
| 1.67±0.58c$ d: a$ k$ B" H0 ? V7 P0 X
| 2.75±0.96bc
: Y3 R. J. P6 A9 B | 1.75±0.96b: t+ x6 C, Q8 O2 n
| 1.00±0.00d
: k5 t. y. X( A7 p c. ^ | 0.25±0.50c6 Q; Q& _1 H+ s8 i0 Y& I! v9 b
| 0.13±0.25c H- I! R/ ~& H# C3 Q; |
| 0* [6 W/ h/ {# w' g/ U7 R& Y
| 0
5 \! J' D/ x; D' O |
359 ?' e9 a! W7 ]% p
| 3.25±0.50ab
* X, Y' I7 a. v | 3.00±0.82bc0 C4 G( c' g# f! |; C. M
| 2.38±0.49b/ O% p8 K2 F6 q, x0 r* O+ `- R
| 2.00±0.00c, N% u* F3 P6 I' z2 G$ k7 a
| 1.00±0.00c/ t9 C( \& H9 R3 n" m
| 0.75±0.50c3 S* t6 ?0 H5 i- f9 d6 W% ^
| 0* ]( W1 |0 f( e* b' ]3 e& _# [* h: r
| 0
1 t) Z0 Q, l7 t9 s# E9 E- D, k |
40' h, A) a8 b R
| 3.00±0.82ab
9 I8 n# |; H5 p2 n$ L/ F | 5.75±1.71a
8 i# }# c% n: D9 O0 m/ F1 \ | 5.00±1.83a
; {# e1 i# y9 [5 P6 f- l | 3.25±1.50b5 R% U5 a) E1 m9 D0 ?! |
| 3.00±0.82b8 H% ^7 d! z7 t# v
| 2.13±0.50b
: u }2 J0 o* w- t3 G9 I/ ^! ~ | 1.83±0.58bc# o# R* {% j: n* m0 q
| 1.03±0.63bc) A) D, z* K9 a( q% h
|
458 q" k2 M5 `! l' }* D0 o5 N% U
| 3.25±1.26ab
$ l4 b& H) q; B3 j6 X# a | 4.25±0.96ab1 L2 N1 f- x4 H# K6 L
| 5.50±1.29a
, g1 y* d1 a. M: n' a | 3.75±0.96b
|5 ~- ] Z" y, Y- h | 3.25±1.26b
1 j+ y8 M6 M; E7 }' n& w3 z | 2.38±1.80b
: R2 P& L% {+ C5 m+ F& ?( K- [ | 2.00±1.41bc
- b u5 Y4 ?8 e/ J S+ _ | 1.13±0.63bc
- ?7 A- u: I. T" B, q" `& i! R |
50
% k6 g% Z2 E. }9 } | 2.25±0.50bc* a+ e) j0 ~6 X! {" {6 r
| 4.25±0.96ab
" ^: b: X& w. \/ c: W( ]9 S | 4.50±2.08a- b3 v1 S& C9 S: k9 R" q, U" l
| 5.75±0.50a
8 F+ [$ p+ [1 ]! @3 h | 6.00±0.00a4 J; p. e& X$ }+ n% I' F# h
| 5.00±0.00a
0 A- ?: ] q3 o | 3.5±0.58ab# P3 R J- X* k8 g
| 1.50±0.58b4 F( X1 Q- {8 {# q, X% ^% F' P, ^
|
55& k% v* K! s; A) Q2 L
| 3.50±0.58a
8 g% w' Z0 Z% U7 v! a0 Z | 4.75±0.50a
5 s5 M7 x( w: V1 g | 6.00±0.82b5 P/ x" C+ T, Y) n5 W
| 5.75±1.50a) y1 o! E0 V: d1 Q! S7 V# k+ y
| 5.25±0.96a, ]* }; ^0 |2 {3 x: k& I
| 4.25±0.50a2 o0 I3 k" `+ q* z8 y9 ^
| 3.25±0.96b1 b) S/ _) B `) A( e& ~- S/ O
| 2.75±1.26ab/ T* T" h p0 v- [6 @4 q4 t3 f
|
60; u8 b1 w) ^6 T+ _! G
| 3.50±0.58a; F0 p' b- J* Y' _/ T6 T) b; ~( c
| 5.00±0.82a
( b+ B% W9 L: m6 G0 ]8 z$ q X | 6.25±0.50a
4 t& [* j, J" T* K- Y | 5.75±0.96a- Q& Z$ V9 s0 J( W# |8 \
| 5.00±0.82a
5 r3 |: ]! o( b5 H/ u; x& l+ a | 4.13±0.85a
* p- W+ C: |* P1 x4 B0 [7 V | 3.25±0.96b" i4 j ]+ |, w0 T, p8 {2 g' `
| 2.25±0.96b6 M% Y# `& K# r
|